Early access to tavapadon for eligible patients
Part of Brain & nervous system clinical trials.
This program provides access to the study drug tavapadon for patients who have no other suitable treatment options and cannot join a clinical trial. It is designed to offer an alternative when standard treatments are not available.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must not have any other suitable treatment options available to you.
- You must not qualify for any ongoing clinical trials for your condition.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests an investigational drug called GT-02287 in people with early-stage Parkinson's disease (diagnosed within the last 7 years). The goal is to see if it is safe and how the body processes it, with a special focus on people with certain genetic changes (GBA1 mutations) that may be linked to Parkinson's.
This trial is testing if a medicine called tenofovir, usually used for HIV and hepatitis B, can help people with early-stage Parkinson's disease. It's for people who are under 65 and have no other major health issues.
This trial tests a new oral medicine, GT-02287, to see if it can help people with early Parkinson's disease. It aims to improve symptoms and slow the disease, and it also tracks how the medicine affects certain markers in the body.
This trial tests whether the anti-inflammatory drug dapansutrile can help people with early Parkinson's disease. You would get either dapansutrile or a placebo (a pill with no active drug) to see if it slows the disease.
This study looks at real-world experiences of people with Parkinson's who are using ONAPGO, a medication given continuously under the skin through a pump. The goal is to understand how this treatment works in daily life.
This trial tests several experimental drugs at once to find new treatments for Parkinson's disease. If you have Parkinson's and take medication, you may be able to join and help speed up research.
Hear when a new Parkinson Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.